CTRI/2022/05/042681已完成未知
Clinical Evaluation of Vidanga Churna and Vyoshadi Guggulu in the Management of Medoroga (Obesity)
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •i)Obese subjects of BMI ( >25 to 39.9 kg/m2)
- •ii)Obese patients of either sex and of age between 18 – 45 years
- •iii)Willing to participate in the study
排除标准
- •i)Obesity due to secondary causes – Hypothyroidism, PCOD,
- •Cushing’s syndrome etc.
- •ii)Patients with poorly controlled Hypertension
- •(BP > 160 / 100 mm Hg)
- •iii)Patients with uncontrolled Diabetes Mellitus having HbA1C >8%
- •iv)Patients who are on corticosteroids, Ca++ channel blockers,
- •Anti-psychotics, antidepressants, anti-cholinergic, anti-epileptics,
- •immune-suppressants, Hormonal replacement therapy or any
- •other drugs that may have an influence on outcome of study.
- •v)Patients with the H/O significant systemic illness which might
- •interfere with the compliance of the trail drug (Rheumatoid
- •arthritis, Tuberculosis, Inflammatory Bowel Disease etc.).
- •vi)Patients who have a past history of Cardiac Arrhythmia,
- •Acute Coronary Syndrome, Myocardial Infarction, Stroke
- •or Severe Arrhythmia in the last 6 months.
- •vii)Symptomatic patients with clinical evidence of congestive
- •cardiac failure.
- •viii)Known cases of HIV and AIDS &Patients suffering with malignancy.
- •ix) Patients with concurrent serious hepatic disorders (defined as
- •Aspartate Amino Transferase (AST) and / or Alanine Amino
- •Transferase (ALT) > 2 times upper normal limit) or Renal Disorders
- •(defined as S. Creatinine >1.2mg/dL), Severe Pulmonary Dysfunction
- •(uncontrolled Bronchial Asthma and / or Chronic Obstructive
- •Pulmonary Disease (COPD)
- •x) Women who are planning for conception / pregnant or lactating.
- •xi) H/o hypersensitivity to any of the trial drugs or their ingredients.
- •xii)Any other condition which the Investigator thinks may jeopardize
研究者
相似试验
已完成
2 期
Tonic in coldCTRI/2020/05/025105PRIYANKA PANCHOLA40
已完成
2 期
To assess the effect of Ayurvedic medicines on Kidney stone (urolithiasis)CTRI/2018/11/016388Central Council for Research in Ayurvedic Sciences CCRAS50
尚未招募
2 期
A clinical study to evaluate the effects of Vasadi Kwath and Nitya virechan Karma in patients with uncomplicated tamak swasa(Bronchial asthma)CTRI/2023/11/059879Dr Motiur Rahman
尚未招募
2 期
A CLINICAL TRIAL ON AYURVEDIC PANCHAKARMATHEREPY IN EXESSIVE MENSTRUAL FLOWCTRI/2022/02/039967ational institute of Ayurveda Jaipur Rajasthan
尚未招募
不适用
Anemia and its management through AyurvedaCTRI/2020/11/028907Dr Sarvepalli Radhakrishnan Rajasthan Ayurved University Jodhpur